false2025-12-31Q20001075880--06-30 0001075880 2025-07-01 2025-12-31 0001075880 2024-07-01 2024-12-31 0001075880 2024-12-31 0001075880 2024-06-30 0001075880 2025-06-30 0001075880 2025-12-31 0001075880 2025-12-02 2025-12-02 0001075880 2025-12-10 0001075880 2025-07-25 0001075880 2025-07-31 2025-07-31 0001075880 2025-07-01 0001075880 2025-01-01 2025-06-30 0001075880 2025-12-02 0001075880 2025-07-31 0001075880 2022-05-01 0001075880 2024-09-04 2024-09-04 0001075880 2025-12-31 2025-12-31 0001075880 ifrs-full:RetainedEarningsMember 2025-07-01 2025-12-31 0001075880 ifrs-full:IssuedCapitalMember 2025-07-01 2025-12-31 0001075880 kzia:OtherContributedEquityMember 2025-07-01 2025-12-31 0001075880 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-07-01 2025-12-31 0001075880 kzia:ForeignCurrencyTranslationReserveMember 2025-07-01 2025-12-31 0001075880 ifrs-full:IssuedCapitalMember kzia:IssueDateTwentyfiveJulyTwoThousandTwentyfiveMember kzia:MaximWarrantsNetSettlementMember 2025-07-01 2025-12-31 0001075880 ifrs-full:IssuedCapitalMember kzia:IssueDateFiveAugustTwoThousandTwentyfiveMember kzia:AugustPIPEMember 2025-07-01 2025-12-31 0001075880 ifrs-full:IssuedCapitalMember kzia:IssueDateTwentyAugustTwoThousandTwentyfiveMember kzia:ATMissueofsharesNumberSixtyFiveMember 2025-07-01 2025-12-31 0001075880 ifrs-full:IssuedCapitalMember kzia:IssueDateTwentysevenAugustTwoThousandTwentyfiveMember kzia:ATMIssueOfSharesNunmberSixtySixMember 2025-07-01 2025-12-31 0001075880 ifrs-full:IssuedCapitalMember kzia:IssueDateTwelveSeptemberTwoThousandTwentyfiveMember kzia:ATMIssueOfSharesNumberSixtySevenMember 2025-07-01 2025-12-31 0001075880 ifrs-full:IssuedCapitalMember kzia:IssueDateThreeOctoberTwoThousandTwentyfiveMember kzia:ATMIssueOfSharesNumberSixtyEightMember 2025-07-01 2025-12-31 0001075880 ifrs-full:IssuedCapitalMember kzia:IssueDateThreeDecemberTwoThousandTwentyfiveMember kzia:DecemberPIPENetofTransactionCostsMember 2025-07-01 2025-12-31 0001075880 ifrs-full:IssuedCapitalMember kzia:IssueDateTenDecemberTwoThousandTwentyfiveMember kzia:AlumniWarrantsNetSettlementMember 2025-07-01 2025-12-31 0001075880 kzia:IssueDateTwentyfiveJulyTwoThousandTwentyfiveMember kzia:MaximWarrantsNetSettlementMember 2025-07-01 2025-12-31 0001075880 kzia:IssueDateFiveAugustTwoThousandTwentyfiveMember kzia:AugustPIPEMember 2025-07-01 2025-12-31 0001075880 kzia:IssueDateTwentyAugustTwoThousandTwentyfiveMember kzia:ATMissueofsharesNumberSixtyFiveMember 2025-07-01 2025-12-31 0001075880 kzia:IssueDateTwentysevenAugustTwoThousandTwentyfiveMember kzia:ATMIssueOfSharesNunmberSixtySixMember 2025-07-01 2025-12-31 0001075880 kzia:IssueDateTwelveSeptemberTwoThousandTwentyfiveMember kzia:ATMIssueOfSharesNumberSixtySevenMember 2025-07-01 2025-12-31 0001075880 kzia:IssueDateThreeOctoberTwoThousandTwentyfiveMember kzia:ATMIssueOfSharesNumberSixtyEightMember 2025-07-01 2025-12-31 0001075880 kzia:IssueDateThreeDecemberTwoThousandTwentyfiveMember kzia:DecemberPIPENetofTransactionCostsMember 2025-07-01 2025-12-31 0001075880 kzia:IssueDateTenDecemberTwoThousandTwentyfiveMember kzia:AlumniWarrantsNetSettlementMember 2025-07-01 2025-12-31 0001075880 kzia:ShareIssueTransactionCostsMember 2025-07-01 2025-12-31 0001075880 ifrs-full:IssuedCapitalMember kzia:ShareIssueTransactionCostsMember 2025-07-01 2025-12-31 0001075880 ifrs-full:IssuedCapitalMember 2024-07-01 2024-12-31 0001075880 kzia:OtherContributedEquityMember 2024-07-01 2024-12-31 0001075880 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-07-01 2024-12-31 0001075880 kzia:ForeignCurrencyTranslationReserveMember 2024-07-01 2024-12-31 0001075880 ifrs-full:RetainedEarningsMember 2024-07-01 2024-12-31 0001075880 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2025-12-31 0001075880 kzia:BasReceivablesMember 2025-12-31 0001075880 kzia:DepositsHeldMember 2025-12-31 0001075880 kzia:InsurancePremiumFundingMember 2025-12-31 0001075880 kzia:CorporateCreditCardDepositMember 2025-12-31 0001075880 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2025-06-30 0001075880 kzia:BasReceivablesMember 2025-06-30 0001075880 kzia:DepositsHeldMember 2025-06-30 0001075880 kzia:InsurancePremiumFundingMember 2025-06-30 0001075880 kzia:CorporateCreditCardDepositMember 2025-06-30 0001075880 kzia:UnsecuredConvertiblePromissoryNoteMember 2023-10-23 0001075880 kzia:UnsecuredConvertiblePromissoryNoteMember 2023-12-23 2023-12-23 0001075880 kzia:UnsecuredConvertiblePromissoryNoteMember 2023-12-23 0001075880 kzia:UnsecuredConvertiblePromissoryNoteMember kzia:AmericanDepositarySharesMember 2023-12-23 0001075880 kzia:UnsecuredConvertiblePromissoryNoteMember kzia:AmericanDepositarySharesMember 2024-06-19 0001075880 kzia:UnsecuredConvertiblePromissoryNoteMember ifrs-full:OrdinarySharesMember 2024-06-19 0001075880 kzia:SecuritiesPurchaseAgreementMember 2025-12-02 2025-12-02 0001075880 kzia:PrivatePlacementofEquitySecuritiesMember 2025-12-02 2025-12-02 0001075880 kzia:PrivatePlacementofEquitySecuritiesMember 2025-07-31 0001075880 kzia:SecuritiesPurchaseAgreementMember kzia:PrefundedWarrantsMember 2025-07-31 0001075880 kzia:PrivatePlacementofEquitySecuritiesMember kzia:PrefundedWarrantsMember 2025-07-31 0001075880 kzia:PrivatePlacementofEquitySecuritiesMember 2025-07-31 2025-07-31 0001075880 kzia:PrivatePlacementofEquitySecuritiesMember 2025-12-02 0001075880 kzia:SecuritiesPurchaseAgreementMember kzia:PrefundedWarrantsMember 2025-12-02 0001075880 kzia:PrivatePlacementofEquitySecuritiesMember kzia:PrefundedWarrantsMember 2025-12-02 0001075880 kzia:ForeignCurrencyTranslationReserveMember 2025-06-30 0001075880 ifrs-full:RetainedEarningsMember 2025-06-30 0001075880 ifrs-full:IssuedCapitalMember 2025-06-30 0001075880 kzia:OtherContributedEquityMember 2025-06-30 0001075880 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-06-30 0001075880 ifrs-full:IssuedCapitalMember kzia:IssueDateOneJulyTwoThousandTwentyfiveMember 2025-06-30 0001075880 ifrs-full:IssuedCapitalMember kzia:IssueDateThirtyoneDecemberTwoThousandTwentyfiveMember 2025-12-31 0001075880 ifrs-full:IssuedCapitalMember 2025-12-31 0001075880 kzia:OtherContributedEquityMember 2025-12-31 0001075880 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-12-31 0001075880 kzia:ForeignCurrencyTranslationReserveMember 2025-12-31 0001075880 ifrs-full:RetainedEarningsMember 2025-12-31 0001075880 ifrs-full:IssuedCapitalMember 2024-06-30 0001075880 kzia:OtherContributedEquityMember 2024-06-30 0001075880 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-06-30 0001075880 kzia:ForeignCurrencyTranslationReserveMember 2024-06-30 0001075880 ifrs-full:RetainedEarningsMember 2024-06-30 0001075880 ifrs-full:IssuedCapitalMember 2024-12-31 0001075880 kzia:OtherContributedEquityMember 2024-12-31 0001075880 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-12-31 0001075880 kzia:ForeignCurrencyTranslationReserveMember 2024-12-31 0001075880 ifrs-full:RetainedEarningsMember 2024-12-31 iso4217:AUD xbrli:shares iso4217:USD xbrli:pure iso4217:AUD xbrli:shares iso4217:USD xbrli:shares
SECURITIES AND EXCHANGE COMMISSION
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE
13a-16
OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of
March
,
2026 Commission File Number
000-29962
Kazia Therapeutics Limited
(Translation of registrant’s name into English)
Three International Towers Level 24 300 Barangaroo Avenue Sydney NSW 2000
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form
20-F
or Form
40-F.
INFORMATION CONTAINED IN THIS FORM
6-K
REPORT
On March 16, 2026 AEDT, Kazia Therapeutics Limited (the “Company”) reported its unaudited half-year results for the six months ended December 31, 2025, a copy of which is attached to this Form
6-K
as Exhibit 99.1.
The Company hereby incorporates by reference the information contained herein, including Exhibit 99.1, into the Company’s
registration
statements on Form
F-3
(File
No. 333-281937).
|
|
|
|
|
|
|
|
| 99.1 |
|
Half-year report for the six months ended December 31, 2025 |
|
|
| 101.INS |
|
XBRL Instance Document |
|
|
| 101.SCH |
|
XBRL Taxonomy Extension Schema Document |
|
|
| 101.CAL |
|
XBRL Taxonomy Extension Calculation Linkbase Document |
|
|
| 101.DEF |
|
XBRL Taxonomy Extension Definition Linkbase Document |
|
|
| 101.LAB |
|
XBRL Taxonomy Extension Label Linkbase Document |
|
|
| 101.PRE |
|
XBRL Taxonomy Extension Presentation Linkbase Document |
|
|
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document ) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Kazia Therapeutics Limited (Registrant) |
|
| /s/ John Friend |
| Name: John Friend |
| Title: Chief Executive Officer |
|
| Date: March 19, 2026 |
ATTACHMENTS / EXHIBITS
EX-99.1
XBRL TAXONOMY EXTENSION SCHEMA
IDEA: R1.htm
IDEA: R2.htm
IDEA: R3.htm
IDEA: R4.htm
IDEA: R5.htm
IDEA: R6.htm
IDEA: R7.htm
IDEA: R8.htm
IDEA: R9.htm
IDEA: R10.htm
IDEA: R11.htm
IDEA: R12.htm
IDEA: R13.htm
IDEA: R14.htm
IDEA: R15.htm
IDEA: R16.htm
IDEA: R17.htm
IDEA: R18.htm
IDEA: R19.htm
IDEA: R20.htm
IDEA: R21.htm
IDEA: R22.htm
IDEA: R23.htm
IDEA: R24.htm
IDEA: R25.htm
IDEA: R26.htm
IDEA: R27.htm
IDEA: R28.htm
IDEA: R29.htm
IDEA: R30.htm
IDEA: R31.htm
IDEA: R32.htm
IDEA: R33.htm
IDEA: R34.htm
IDEA: R35.htm
IDEA: R36.htm
IDEA: R37.htm
IDEA: R38.htm
IDEA: R39.htm
IDEA: R40.htm
IDEA: R41.htm
IDEA: R42.htm
IDEA: R43.htm
IDEA: R44.htm
IDEA: R45.htm
IDEA: R46.htm
IDEA: R47.htm
IDEA: R48.htm
IDEA: R49.htm
IDEA: R50.htm
IDEA: R51.htm
IDEA: R52.htm
IDEA: R53.htm
IDEA: R54.htm
IDEA: R55.htm
IDEA: R56.htm
IDEA: R57.htm
IDEA: R58.htm
IDEA: R59.htm
IDEA: R60.htm
IDEA: R61.htm
IDEA: FilingSummary.xml
IDEA: MetaLinks.json
IDEA: d45630d6k_htm.xml
